CAS: 923032-37-5 - Refametinib
Formula:C19H20F3IN2O5S
InChI:InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1
InChI key:InChIKey=RDSACQWTXKSHJT-NSHDSACASA-N
SMILES:O=S(=O)(NC=1C(OC)=CC(F)=C(F)C1NC2=CC=C(I)C=C2F)C3(CC3)CC(O)CO
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RDEA119 REF: IN-DA00GRCOCAS: 923032-37-5 | % | 63.00 €~538.00 € | Tue 07 Jan 25 |
 | Refametinib REF: 54-BISN0230CAS: 923032-37-5 | - - - | 107.00 €~794.00 € | Mon 13 Jan 25 |
 | Refametinib REF: TM-T6636CAS: 923032-37-5 | 100% - 99.84% | 39.00 €~415.00 € | Mon 13 Jan 25 |
 | Refametinib REF: 3D-FR104239CAS: 923032-37-5 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA00GRCO
| 5mg | 63.00 € | ||
| 10mg | 103.00 € | ||
| 50mg | 200.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 54-BISN0230
| 50mg | 286.00 € | ||
| 100mg | 474.00 € | ||
| 250mg | 794.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Refametinib
CAS:923032-37-5
Refametinib (RDEA119) (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 …
Formula:
C19H20F3IN2O5S
Purity:
100% - 99.84%
Color and Shape:
Solid
Molecular weight:
572.34
Ref: TM-T6636
| 1mg | 39.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 107.00 € | ||
| 25mg | 182.00 € | ||
| 50mg | 276.00 € | ||
| 100mg | 415.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Refametinib
CAS:923032-37-5
Inhibitor of MEK1 and MEK2 kinases
Formula:
C19H20F3IN2O5S
Purity:
Min. 95%
Molecular weight:
572.34 g/mol
Ref: 3D-FR104239
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
